Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in Melanoma

DSpace/Manakin Repository

Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in Melanoma

Citable link to this page

 

 
Title: Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in Melanoma
Author: Wu, Xin-Qi; Marmarelis, Melina Elpi; Hodi, Frank Stephen

Note: Order does not necessarily reflect citation order of authors.

Citation: Wu, Xinqi, Melina E. Marmarelis, and F. Stephen Hodi. 2013. Activity of the heat shock protein 90 inhibitor ganetespib in melanoma. PLoS ONE 8(2): e56134.
Full Text & Related Files:
Abstract: Heat shock protein 90 (HSP90) is involved in the regulation of diverse biological processes such as cell signaling, proliferation and survival, and has been recently recognized as a potential target for cancer therapy. Ganetespib is a potent ATP competitive inhibitor of HSP90. Ganetespib downregulated the expression of multiple signal transducing molecules including EGFR, IGF-1R, c-Met, Akt, B-RAF and C-RAF, resulting in pronounced decrease in phosphorylation of Akt and Erk1/2 in a panel of five cutaneous melanoma cell lines including those harboring B-RAF and N-RAS mutations. Ganetespib exhibited potent antiproliferative activity on all five of these cell lines, with IC50 values between 37.5 and 84 nM. Importantly, Ganetespib is active on B-RAF mutated melanoma cells that have acquired resistance to B-RAF inhibition. Ganetespib induced apoptosis and cell cycle arrest at G1 and/or G2/M phase. Ganetespib induced cell cycle arrest was accompanied by altered expression of cyclin-dependent kinase inhibitor (CDKI) p21Cip1 and p27Kip1, cyclins B1, D1 and E, and/or cyclin-dependent kinases 1, 2 and 4. HSP90 is functionally important for melanoma cells and HSP90 inhibitors such as ganetespib could potentially be effective therapeutics for melanoma with various genetic mutations and acquired resistance to B-RAF inhibition.
Published Version: doi:10.1371/journal.pone.0056134
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572008/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:11180366
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters